Clinical feature | Group | Sample size(Male/Female) | Age (years) | Side(Left/Right) | Type (Ischemic/ Hemorrhagic) | Course of disease | TBS protocol | Targeted Area | Outcomes | Follow-up | Adjuvant therapy | Adverse effects (n) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cognitive impairment | ||||||||||||
Li et al.[18] | iTBS | 16/12 | 69.50 ± 9.50 | 16/12 | 18/10 | 25.00 d | 600 pulses, 100% RMT, 1 sess/d, 2 weeks | LH DLPFC | MMSE, OCS | / | Conventional rehabilitation therapies | sneezing: 1 |
sham | 18/12 | 66.00 ± 13.00 | 24/6 | 14/16 | 25.00 d | / | ||||||
Chu et al.[19] | iTBS | 18/3 | 57.24 ± 14.03 | 12/9 | 13/8 | 4.00 ± 5.00 mon | 600 pulses, 70% RMT, 1 sess/d, 6 weeks | LH DLPFC | MMSE, LOTCA, | / | Computer- assisted rehabilitation therapy | / |
sham | 13/7 | 66.75 ± 12.23 | 13/7 | 12/8 | 6.00 ± 4.00 mon | |||||||
Tsai et al.[17] | iTBS | 11/4 | 60.13 ± 14.10 | Left | 7/8 | 18.47 ± 20.21 d | 600 pulses, 80% RMT, 1 sess/d, 2 weeks | LH DLPFC | RBANS | / | N/A | / |
sham | 13/2 | 56.23 ± 12.00 | 10/5 | 38.00 ± 7.90 d | ||||||||
Visuospatial neglect | ||||||||||||
Koch et al.[21] | cTBS | N/A | 61.40 ± 13.02 | Right | Ischemic | 46.80 d | 600 pulses, 80% AMT, 2 sess/d, 2 weeks | LH PPC | BIT | 2 weeks | Computer- assisted rehabilitation therapy | / |
sham | N/A | 71.89 ± 4.86 | 36.90 d | |||||||||
Fu et al.[11] | cTBS | 8/2 | 55.10 ± 13.96 | Right | 5/5 | 43.70 ± 23.50 d | 801 pulses, 80% RMT, 4 sess/d, 14 days | LH PPC | SCT, LBT | 4 weeks | Conventional rehabilitation therapies | slight dizziness: 2 |
sham | 8/2 | 59.50 ± 12.68 | 59.50 ± 12.00 d | / | ||||||||
Yang et al.[9] | cTBS | 5/4 | 49.45 ± 10.78 | N/A | 6/3 | 104.85 ± 36.38 d | 801 pulses, 80% RMT, 4 sess/d, 2 weeks | LH PPC | SCT, LBT | 1 mon | Conventional rehabilitation therapies | N/A |
sham | 3/7 | 47.70 ± 11.81 | 6/4 | 105.91 ± 37.59 d | ||||||||
Fu et al.[22] | cTBS | 9/3 | 60.17 ± 14.05 | Right | N/A | 41.83 ± 20.56 d | 600 pulses, 80% RMT, 4sess/day, 10 days | LH PPC | SCT, LBT | / | Conventional rehabilitation therapies | / |
control | 62.00 ± 9.78 | N/A | 36.17 ± 17.50 d | 600 pulses, 40% RMT, 4 sess/day, 10 days | ||||||||
Cao et al.[20] | iTBS | 6/1 | 55.00 ± 12.00 | Right | N/A | 32.00 ± 17.00 d | 600 pulses, 80% RMT, 2 sess/day, 2 weeks | LH DLPFC | SCT, LBT | / | Conventional rehabilitation therapies | N/A |
control | 5/1 | 62.00 ± 10.00 | N/A | 36.00 ± 17.00 d | 600 pulses, 40% RMT, 2 sess/day, 2 weeks | |||||||
Nyffeler et al.[13] | 8cTBS | 5/5 | 67.80 ± 10.13 | Right | N/A | 26.80 ± 20.89 d | 801 pulses, 100% RMT, 4sess/day, 2 days | LH PPC | CBS | 3 mons | Conventional rehabilitation therapies | / |
16cTBS | 6/4 | 74.30 ± 10.23 | N/A | 22.90 ± 10.34 d | 801 pulses, 100% RMT, 4 sess/day, 4 days | |||||||
sham | 7/3 | 70.60 ± 11.44 | N/A | 25.80 ± 11.26 d | 801 pulses, 100% RMT, 4sess/day, 2 days | |||||||
Hopfner et al.[10] | cTBS | 5/7 | 62.00 ± 10.60 | Right | N/A | 32.42 ± 11.95 d | 801 pulses, 100% AMT, 2 sess/day, 2 weeks | LH PPC | BCT | / | Smooth pursuit training | N/A |
sham | 4/2 | 65.40 ± 15.20 | N/A | 32.42 ± 11.95 d | ||||||||
Vatanparasti et al.[12] | cTBS | 5/2 | 67.50 ± 8.40 | N/A | 4/3 | N/A | 801 pulses, 80% RMT, 1 sess/day, 2 weeks | LH PPC | SCT, LBT | / | Prism adaptation | / |
sham | 5/2 | 65.50 ± 10.20 | 4/3 | N/A | ||||||||
Aphasia | ||||||||||||
Chou et al.[26] | iTBS | 15/14 | 62.70 ± 12.70 | Left | 20/9 | 17.60 ± 20.80 mon | 600 pulses, 80% RMT, 1 sess/day, 2 weeks | LH IFG | CCAT | / | Speech and language therapy | / |
sham | 20/9 | 61.60 ± 14.70 | 20/9 | 16.50 ± 24.60 mon | ||||||||
Allendorfer et al.[24] | iTBS | 12/6 | 59.61 ± 10.54 | Left | Ischemic | 4.62 ± 4.17 y | 600 pulses, 80% AMT, 1 sess/day, 3 weeks | LH IFG | BNT,SFT,COWAT, WAB-R AQ,PPVT, | 3 mons | N/A | N/A |
Sham | 4/2 | 43.78 ± 13.98 | 3.94 ± 3.56 y | |||||||||
Szaflarski et al.[25] | iTBS | 14/7 | 59.39 ± 13.83 | Left | Ischemic | 3.90 ± 4.02 y | 600 pulses, 80% AMT, 1 sess/day, 3 weeks | LH IFG | BNT,SFT,COWAT, WAB | 3 mons | N/A | N/A |
sham | 4/2 | 48.78 ± 11.34 | 4.62 ± 4.02 y | |||||||||
Zheng et al.[23] | cTBS | 13/2 | 53.13 ± 11.26 | Left | N/A | 42.80 ± 12.91 d | 600 pulses, 80% AMT, 1 sess/day, 3 weeks | RH pSTG | WAB-AQ | / | Speech and language therapy | N/A |
Sham | 11/3 | 66.33 ± 13.77 | N/A | 50.50 ± 21.93 d | ||||||||
Spasticity /Upper Extremity /Hand | ||||||||||||
Chen et al.[29] | iTBS | 7/4 | 52.90 ± 11.10 | 6/5 | 2/9 | > 6 mon | 600 pulse, 80% AMT, 1 sess/day, 2 weeks | AH M1 | MAS, FMA-UE, ARAT | / | Physical and occupational therapy | / |
sham | 7/4 | 52.60 ± 8.30 | 9/2 | 3/8 | ||||||||
Kuzu et al.[27] | cTBS | 6/1 | 61.30 ± 9.80 | 2/5 | Ischemic | 14.50 ± 1.60 mon | 600 pulse, 80% AMT, 1 sess/day, 2 weeks | UH M1 | MAS, FMA-UE | 4 weeks | Conventional rehabilitation therapies | / |
sham | 2/4 | 65.00 ± 4.60 | 3/3 | 14.50 ± 2.00 mon | ||||||||
Chen et al.[28] | iTBS | 13/3 | 57.38 ± 8.04 | 4/12 | 10/6 | 80.13 ± 35.19 d | 600 pulse, 80% AMT, 1 sess/day, 2 weeks | Ipsilesional CB | MAS | / | Physical therapy | / |
sham | 12/4 | 51.44 ± 9.19 | 9/7 | 8/8 | 101.50 ± 54.15 d | |||||||
Watanabe et al.[31] | iTBS | 5/3 | 72.50 ± 6.50 | 4/4 | N/A | < 1 week | 600 pulses, 110%RMT, 1 sess /day, 10 days | AH M1 | FMA-UE, MAS | / | Conventional rehabilitation therapies | / |
sham | 3/3 | 75.20 ± 5.50 | 1/5 | N/A | ||||||||
Ackerley et al.[32] | iTBS | 6/3 | 61 | 3/6 | N/A | 20 mon | 600 pulses, 90% AMT, 1 sess /day, 10 days | AH M1 | FMA-UE, ARAT | 1 mon and 3 mons | Conventional rehabilitation therapies | / |
sham | 6/3 | 71 | 3/6 | N/A | 18 mon | |||||||
Chen et al.[33] | iTBS | 8/4 | 54.36 ± 10.56 | 7/5 | 6/6 | 5.01 ± 4.39 mon | 600 pulses, 80% AMT, 2 sess/day, 15 days | AH M1 | MAS, FMA-UE, ARAT, NHPT, BBT, | / | Virtual reality-based cycling training | / |
sham | 10/1 | 48.95 ± 9.63 | 7/4 | 2/9 | 7.99 ± 5.41 mon | |||||||
Talelli et al.[38] | iTBS | 7/6 | 54.4 ± 15.8 | 9/4 | Ischemic | 17.50 ± 5.10 mon | 600 pulses, 80% AMT, 1 sess /day; 2 weeks | AH M1 | NHPT, JTT, grip strength | 1 mon and 3 mons | Physical therapy | / |
sham | 9/3 | 58.5 ± 12.0 | 5/7 | 38.50 ± 57.20 mon | ||||||||
cTBS | 7/5 | 55.8 ± 12.4 | 2/10 | 29.80 ± 19.70 mon | 600 pulses, 80% AMT, 1 sess /day, 2 weeks | UH M1 | ||||||
sham | 6/6 | 59.4 ± 12.4 | 7/5 | 49.60 ± 76.90 mon | ||||||||
Sung et al.[34] | iTBS | 9/3 | 64.20 ± 11.90 | N/A | 8/4 | 8.10 ± 1.5 mon | 600 pulses, 80% AMT, 10 sess/day, 4 weeks | AH M1 | FMA-UE, WMFT | / | Physical therapy and occupational therapy | / |
sham | 11/3 | 63.10 ± 12.80 | N/A | 9/5 | 8.20 ± 1.60 mon | |||||||
Khan et al.[35] | TBS | 13/7 | 63.55 ± 12.67 | 6/14 | Ischemic | 17.10 ± 4.82 d | 600 pulses, 60%RMT, 1 sess /day, 4 weeks | iTBS to AH M1 + cTBS to UH M1 | FMA-UE | 3 mon, 6 mon and 1 y | Physical therapy | N/A |
no sti | 12/8 | 64.60 ± 12.99 | 5/15 | 16.40 ± 5.58 d | ||||||||
Di Lazzaro et al.[37] | cTBS | 3/3 | 59.5 ± 12.4 | 1/5 | Ischemic | 34.80 ± 17.50 mon | 600 pulses, 80% AMT, 1 sess /day, 10 days | AH M1 | ARAT, NHPT, JTT | 1 mon and 3 mons | Physical therapy | / |
sham | 4/2 | 57.5 ± 12.3 | 2/4 | 30.00 ± 27.60 mon | ||||||||
Zhang et al.[36] | cTBS + iTBS | 9/5 | 58.21 ± 9.00 | 8/6 | 6/8 | 50.57 ± 32.01 mon | 600 pulses, 70% RMT, 1 sess /day, 3 weeks | AH M1 | FMA-UE, ARAT | 2 weeks | Robot- assisted training | N/A |
sham cTBS + iTBS | 7/7 | 59.50 ± 8.56 | 8/6 | 8/6 | 63.93 ± 46.80 mon | |||||||
sham cTBS + sham iTBS | 8/6 | 64.00 ± 5.39 | 7/7 | 10/4 | 50.86 ± 29.50 mon | |||||||
Nicolo et al.[30] | cTBS [14] | 7/7 | 62.40 ± 12.30 | 4/10 | 13/1 | 5.30 ± 1.80 weeks | 600 pulses, 70% RMT, 3 sess/week, 3 weeks | UH M1 | FMA-UE, NHPT | 1 mon | Physical therapy | / |
sham [13] | 8/5 | 64.30 ± 17.10 | 3/10 | 10/3 | 4.70 ± 1.40 weeks | |||||||
Lower Extremity /Balance | ||||||||||||
Koch et al.[40] | iTBS | 13/4 | 64.00 ± 11.30 | 6/11 | Ischemic | 15.18 ± 6.63 mon | 600 pulse, 80% AMT, 2 sess/day, 3 weeks | ipsilesional CB | BBS, FMA-LE | 3 weeks | Physical therapy | / |
sham | 10/7 | 8/9 | 15.88 ± 6.00 mon | |||||||||
Liao et al.[42] | iTBS | 12/3 | 51.53 ± 9.22 | 11/4 | 7/8 | 70.40 ± 44.43 d | 600 pulse, 80% AMT, 1 sess/day, 2 weeks | ipsilesional CB | BBS, FMA-LE | / | Physical therapy | slight headache: 1 |
sham | 9/6 | 55.40 ± 8.10 | 9/6 | 8/7 | 86.53 ± 45.26 d | / | ||||||
Lin et al.[41] | iTBS | 1/9 | 60.80 ± 8.10 | 5/5 | 7/3 | 359.00 ± 171.00 d | 1200 pulses, 100% midline MT, 2 sess/week, 5 weeks | Bilateral M1 | BBS, FMA-LE | / | Conventional rehabilitation therapies | / |
sham | 2/8 | 61.10 ± 9.70 | 6/4 | 9/1 | 384.00 ± 270.00 d | |||||||
Xie et al.[39] | iTBS | 13/5 | 52.35 ± 8.62 | 7/11 | 10/8 | 2.22 ± 1.70 mon | 600 pulse, 80% AMT, 1 sess/day, 2 weeks | contralesional CB | FMA-LE | / | Conventional rehabilitation therapies | / |
sham | 11/7 | 54.41 ± 7.01 | 6/12 | 10/8 | 2.91 ± 1.96 mon | |||||||
Dysphagia | ||||||||||||
Xie et al.[43] | iTBS | 12/6 | 66.90 ± 11.30 | 9/9 | 14/4 | 21.10 ± 20.11 d | 600 pulses, 80% RMT, 1 sess/day, 2 weeks | Affected suprahyoid motor cortex | SSA, WST, MSS, PAS | 2 weeks | Conventional swallowing therapy | / |
sham | 14/6 | 62.80 ± 13.00 | 8/12 | 13/7 | 23.70 ± 16.00 d | |||||||
Rao et al.[44] | iTBS | 22/11 | 63.42 ± 10.35 | 14/18 | 15/18 | 22.00 ± 8.00 d | 600 pulses, 100% RMT, 1 sess/day, 2 weeks | Bilateral CB | FEDSS, PAS,SSA, FOIS | 4 weeks | Conventional swallowing therapy | slight dizziness: 3 |
sham | 24/7 | 65.90 ± 11.42 | 12/12 | 19/12 | 26.00 ± 3.00 d | / |